Nektar Therapeutics (NKTR)
0.60
-0.04 (-5.91%)
At close: Apr 16, 2025, 3:59 PM
0.61
0.96%
After-hours: Apr 16, 2025, 08:00 PM EDT
Nektar Therapeutics Revenue
Nektar Therapeutics reported an annual revenue of $98.43M, reflecting a 9.22% growth. For the quarter ending December 31, 2024, Nektar Therapeutics generated $29.18M in revenue.
Revenue (ttm)
$98.43M
Revenue Growth
9.22%
Price / Sales Ratio
1.94
Revenue / Employee
$1.61M
Employees
61
Market Cap
112.28M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 98.43M | +9.22% |
Dec 31, 2023 | 90.12M | -2.10% |
Dec 31, 2022 | 92.06M | -9.67% |
Dec 31, 2021 | 101.91M | -33.36% |
Dec 31, 2020 | 152.91M | n/a |